Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference


PRINCETON, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Bank of America 2024 Health Care Conference in Las Vegas, NV on Wednesday, May 15, 2024, at 1:40 p.m. P.T.

A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at

About Amicus Therapeutics Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at, and follow on X and LinkedIn.


Investors:Amicus TherapeuticsAndrew FaughnanVice President, Investor (609) 662-3809

Media:Amicus TherapeuticsDiana MooreHead of Global Corporate Affairs and Communications (609) 662-5079


Primary Logo

Source: Amicus Therapeutics, Inc.

In This Story